These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21263073)

  • 1. IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.
    Terawaki S; Chikuma S; Shibayama S; Hayashi T; Yoshida T; Okazaki T; Honjo T
    J Immunol; 2011 Mar; 186(5):2772-9. PubMed ID: 21263073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific activation thresholds of CD8+ T cells are independent of IFN-I-mediated partial lymphocyte activation.
    Wijesundara DK; Kumar S; Alsharifi M; Müllbacher A; Regner M
    Int Immunol; 2010 Sep; 22(9):757-67. PubMed ID: 20682547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.
    Omori R; Eguchi J; Hiroishi K; Ishii S; Hiraide A; Sakaki M; Doi H; Kajiwara A; Ito T; Kogo M; Imawari M
    Cancer Gene Ther; 2012 Sep; 19(9):637-43. PubMed ID: 22790963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-released TLR4 ligands stimulate Gr-1+CD11b+F4/80+ cells to induce apoptosis of activated T cells.
    Liu YY; Sun LC; Wei JJ; Li D; Yuan Y; Yan B; Liang ZH; Zhu HF; Xu Y; Li B; Song CW; Liao SJ; Lei Z; Zhang GM; Feng ZH
    J Immunol; 2010 Sep; 185(5):2773-82. PubMed ID: 20675592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR and IL-12 receptor signals cooperate to activate an individual response element in the IFN-gamma promoter in effector Th cells.
    Zhang F; Nakamura T; Aune TM
    J Immunol; 1999 Jul; 163(2):728-35. PubMed ID: 10395664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
    Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
    J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A developmental stage-specific promoter directs germline transcription of D beta J beta gene segments in precursor T lymphocytes.
    Sikes ML; Gomez RJ; Song J; Oltz EM
    J Immunol; 1998 Aug; 161(3):1399-405. PubMed ID: 9686603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
    Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
    J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
    Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IFN-α as a signal-3 cytokine on human naïve and antigen-experienced CD8(+) T cells.
    Hervas-Stubbs S; Riezu-Boj JI; Gonzalez I; Mancheño U; Dubrot J; Azpilicueta A; Gabari I; Palazon A; Aranguren A; Ruiz J; Prieto J; Larrea E; Melero I
    Eur J Immunol; 2010 Dec; 40(12):3389-402. PubMed ID: 21108462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
    Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
    Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development.
    Zhang XL; Seong R; Piracha R; Larijani M; Heeney M; Parnes JR; Chamberlain JW
    J Immunol; 1998 Sep; 161(5):2254-66. PubMed ID: 9725219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL
    Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
    Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.